Suspension of trading

Income Statement CARMAT Boerse Muenchen

Stocks

CXT

FR0010907956

Medical Equipment, Supplies & Distribution

Real-time Boerse Muenchen 02:44:13 2025-09-25 EDT			5-day change	1st Jan Change
0.0985 ^EUR	-0.51%		-.--%	-

09-01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

768b750192.SUkLDAbFixkXBnLI9RGdOib_YTRoWQ0oyKl6BZYWiqc.IHFEWkCg8m9VcB2bxialfx-eDVAZLm9thMwAXfJ3v8sfHFF_bI3pdyMyQg

Published financial data: CARMAT

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Revenues	-	2.23M	345K	2.8M	6.97M
Other Revenues, Total	9.33K	8K	132K	1.04M	375K
Total Revenues	9.33K	2.24M	477K	3.84M	7.34M
Cost of Goods Sold, Total	20.09M	39.69M	39.44M	39.28M	43.69M
Gross Profit	-20.08M	-37.45M	-38.96M	-35.45M	-36.34M
Selling General & Admin Expenses, Total	15.02M	12.16M	14.71M	21.63M	20.89M
Depreciation & Amortization - (IS)	932K	1.32M	1.68M	1.69M	2.01M
Other Operating Expenses	383K	1.38M	-3.43M	-6.25M	-10M
Other Operating Expenses, Total	16.33M	14.86M	12.96M	17.07M	12.9M
Operating Income	-36.41M	-52.31M	-51.92M	-52.52M	-49.24M
Interest Expense, Total	-2.53M	-3.32M	-3.82M	-3.42M	-3.29M
Interest And Investment Income	-	-	-	373K	121K
Net Interest Expenses	-2.53M	-3.32M	-3.82M	-3.05M	-3.17M
Currency Exchange Gains (Loss)	62.26K	-1K	-27K	-25K	-21K
Other Non Operating Income (Expenses)	-1	1K	-1K	-1K	-
EBT, Excl. Unusual Items	-38.87M	-55.62M	-55.77M	-55.59M	-52.43M
Gain (Loss) On Sale Of Investments	-61.26K	-	-	-	-
Gain (Loss) On Sale Of Assets	116K	-	-	-	-
Asset Writedown	-	-8.1M	-67K	-3K	-
Other Unusual Items	146K	-11K	94K	30K	-621K
EBT, Incl. Unusual Items	-38.67M	-63.74M	-55.74M	-55.57M	-53.05M
Income Tax Expense	-1.71M	-1.86M	-2.06M	-1.7M	-1.66M
Earnings From Continuing Operations	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Net Income to Company	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Net Income - (IS)	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Net Income to Common Incl Extra Items	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Net Income to Common Excl. Extra Items	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Per Share Items
Net EPS - Basic	-2.85	-3.97	-2.37	-2.17	-1.15
Basic EPS - Continuing Operations	-2.85	-3.97	-2.37	-2.17	-1.15
Basic Weighted Average Shares Outstanding	12.97M	15.59M	22.65M	24.82M	44.69M
Net EPS - Diluted	-2.85	-3.97	-2.37	-2.17	-1.15
Diluted EPS - Continuing Operations	-2.85	-3.97	-2.37	-2.17	-1.15
Diluted Weighted Average Shares Outstanding	12.97M	15.59M	22.65M	24.82M	44.69M
Normalized Basic EPS	-1.87	-2.23	-1.54	-1.4	-0.73
Normalized Diluted EPS	-1.87	-2.23	-1.54	-1.4	-0.73
Supplemental Items
EBITDA	-35.48M	-50.99M	-50.24M	-50.83M	-47.23M
EBITA	-36.39M	-52.22M	-51.92M	-52.52M	-49.21M
EBIT	-36.41M	-52.31M	-51.92M	-52.52M	-49.24M
Total Revenues (As Reported)	12.24M	16.68M	9M	18.6M	15.79M
Effective Tax Rate - (Ratio)	4.42	2.92	3.7	3.06	3.13
Normalized Net Income	-24.3M	-34.77M	-34.86M	-34.75M	-32.77M
Non-Cash Pension Expense	129K	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	22.1M	18.89M	14.92M	16.89M	16.94M

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Assets
Cash And Equivalents	35.98M	39.19M	51.43M	8.01M	4.7M
Total Cash And Short Term Investments	35.98M	39.19M	51.43M	8.01M	4.7M
Accounts Receivable, Total	-	464K	140K	1.35M	1.54M
Other Receivables	4.11M	3.36M	3.52M	3.8M	2.71M
Total Receivables	4.11M	3.83M	3.66M	5.14M	4.25M
Inventory	9.9M	14.34M	17.44M	23.94M	19.81M
Prepaid Expenses	188K	610K	1.25M	1.22M	1.04M
Other Current Assets, Total	2.68M	3.7M	3.99M	4.07M	2.55M
Total Current Assets	52.86M	61.67M	77.76M	42.39M	32.35M
Gross Property Plant And Equipment	15.24M	16.85M	17.73M	22.5M	23.41M
Accumulated Depreciation	-8.83M	-10.06M	-11.03M	-12.48M	-14.04M
Net Property Plant And Equipment	6.41M	6.78M	6.7M	10.02M	9.37M
Other Intangibles, Total	17.08K	88K	0	0	73K
Other Long-Term Assets, Total	546K	541K	774K	651K	632K
Total Assets	59.84M	69.08M	85.24M	53.07M	42.43M
Liabilities
Accounts Payable, Total	8.01M	8.39M	6.53M	9.61M	5.23M
Accrued Expenses, Total	4.3M	4.88M	6.26M	6.42M	7.19M
Current Portion of Long-Term Debt	79.44K	133K	2.64M	19.14M	2.29M
Current Income Taxes Payable	145K	530K	138K	136K	172K
Other Current Liabilities	-	-	-	4.91M	4.34M
Total Current Liabilities	12.53M	13.93M	15.56M	40.21M	19.23M
Long-Term Debt	38.86M	51.89M	52.72M	38.5M	55.51M
Pension & Other Post Retirement Benefits	543K	475K	336K	473K	407K
Other Non Current Liabilities	80K	1.83M	144K	817K	1.59M
Total Liabilities	52.02M	68.12M	68.76M	80.01M	76.74M
Common Stock, Total	520K	623K	907K	992K	1.78M
Additional Paid In Capital	29.7M	84.61M	69.73M	9.04M	44.47M
Retained Earnings	-36.96M	-98.84M	-68.91M	-55.1M	-98.49M
Comprehensive Income and Other	14.56M	14.56M	14.75M	18.13M	17.93M
Total Common Equity	7.82M	958K	16.48M	-26.94M	-34.31M
Total Equity	7.82M	958K	16.48M	-26.94M	-34.31M
Total Liabilities And Equity	59.84M	69.08M	85.24M	53.07M	42.43M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.01M	15.56M	22.67M	24.74M	42.49M
ECS Total Common Shares Outstanding	13.01M	15.56M	22.67M	24.74M	42.49M
Book Value / Share	0.6	0.06	0.73	-1.09	-0.81
Tangible Book Value	7.8M	870K	16.48M	-26.94M	-34.38M
Tangible Book Value Per Share	0.6	0.06	0.73	-1.09	-0.81
Total Debt	38.94M	52.02M	55.36M	57.65M	57.8M
Net Debt	2.96M	12.83M	3.93M	49.64M	53.1M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	4.65M	4.68M	5.92M	9.09M	7.34M
Inventories - Work In Process, Total	11.82M	19.05M	15.95M	2.56M	17.83M
Inventories - Finished Goods, Total	944K	3.25M	6.2M	26.58M	6.71M
Machinery, Total	12.6M	15.42M	16.22M	13.8M	21.28M
Full Time Employees	119	160	179	182	153
Part Time Employees	-	-	-	-	-

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Net Income	-36.96M	-61.87M	-53.68M	-53.87M	-51.4M
Depreciation & Amortization - CF	907K	1.23M	1.68M	1.69M	1.98M
Amortization of Goodwill and Intangible Assets - (CF)	24.87K	89K	-	-	34K
Depreciation & Amortization, Total	932K	1.32M	1.68M	1.69M	2.01M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	10.01M	10.08M	673K	6.14M	1.03M
Change In Accounts Receivable	-	-464K	-	-	-
Change In Inventories	-19.6M	-10.58M	-	-	-
Change In Accounts Payable	2.66M	386K	-	-	-
Change In Income Taxes	1.16M	765K	-	-	-
Change in Other Net Operating Assets	-1.23M	194K	-3.05M	-7.45M	5.05M
Cash from Operations	-43.03M	-60.17M	-54.38M	-53.48M	-43.31M
Capital Expenditure	-2.33M	-1.6M	-1.75M	-5.03M	-1.51M
Sale of Property, Plant, and Equipment	-	-	-	-	3K
Sale (Purchase) of Intangible assets	101K	-160K	-	-	-
Investment in Marketable and Equity Securities, Total	-72.02K	13K	-	-	-
Other Investing Activities, Total	-	-	-242K	111K	63K
Cash from Investing	-2.3M	-1.75M	-1.99M	-4.92M	-1.45M
Long-Term Debt Issued, Total	20M	10.12M	-	-	-
Total Debt Issued	20M	10.12M	-	-	-
Long-Term Debt Repaid, Total	-	-	-481K	-1.1M	-831K
Total Debt Repaid	-	-	-481K	-1.1M	-831K
Issuance of Common Stock	5.81M	55.01M	69.08M	7M	41.89M
Other Financing Activities, Total	-	-1K	-1K	9.08M	382K
Cash from Financing	25.81M	65.13M	68.6M	14.98M	41.44M
Miscellaneous Cash Flow Adjustments	1	-	1K	-1K	-4K
Net Change in Cash	-19.52M	3.21M	12.24M	-43.41M	-3.32M
Supplemental Items
Levered Free Cash Flow	-35.36M	-39.46M	-39.64M	-38.2M	-29.74M
Unlevered Free Cash Flow	-33.78M	-37.39M	-37.26M	-36.06M	-27.68M
Change In Net Working Capital	9.73M	4.26M	4.74M	-100K	-2.6M
Net Debt Issued / Repaid	20M	10.12M	-481K	-1.1M	-831K

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Profitability
Return on Assets	-36.55	-50.72	-42.06	-47.47	-64.45
Return on Total Capital	-44.56	-65.56	-52	-64.02	-113.55
Return On Equity %	-157.99	-1.41K	-615.82	1.03K	167.84
Return on Common Equity	-157.99	-1.41K	-615.82	1.03K	167.84
Margin Analysis
Gross Profit Margin %	-215K	-1.67K	-8.17K	-923.85	-494.88
SG&A Margin	161K	543.63	3.08K	563.72	284.4
EBITDA Margin %	-380K	-2.28K	-10.53K	-1.32K	-643.11
EBITA Margin %	-390K	-2.33K	-10.89K	-1.37K	-670.02
EBIT Margin %	-390K	-2.34K	-10.89K	-1.37K	-670.48
Income From Continuing Operations Margin %	-396K	-2.77K	-11.25K	-1.4K	-699.82
Net Income Margin %	-396K	-2.77K	-11.25K	-1.4K	-699.82
Net Avail. For Common Margin %	-396K	-2.77K	-11.25K	-1.4K	-699.82
Normalized Net Income Margin	-260K	-1.55K	-7.31K	-905.56	-446.21
Levered Free Cash Flow Margin	-379K	-1.76K	-8.31K	-995.44	-404.9
Unlevered Free Cash Flow Margin	-362K	-1.67K	-7.81K	-939.72	-376.88
Asset Turnover
Asset Turnover	0	0.03	0.01	0.06	0.15
Fixed Assets Turnover	0	0.34	0.07	0.46	0.76
Receivables Turnover (Average Receivables)	-	-	1.14	3.76	4.83
Inventory Turnover (Average Inventory)	-	3.27	2.48	1.9	2
Short Term Liquidity
Current Ratio	4.22	4.43	5	1.05	1.68
Quick Ratio	3.2	3.09	3.54	0.33	0.47
Operating Cash Flow to Current Liabilities	-3.43	-4.32	-3.49	-1.33	-2.25
Days Sales Outstanding (Average Receivables)	-	-	319.51	97.09	75.84
Days Outstanding Inventory (Average Inventory)	-	111.49	147.06	192.23	183.29
Average Days Payable Outstanding	-	67.8	63.99	64.3	68.65
Cash Conversion Cycle (Average Days)	-	-	402.58	225.02	190.48
Long Term Solvency
Total Debt/Equity	498.02	5.43K	335.99	-214.01	-168.49
Total Debt / Total Capital	83.28	98.19	77.06	187.71	246.01
LT Debt/Equity	497.01	5.42K	319.96	-142.94	-161.8
Long-Term Debt / Total Capital	83.11	97.94	73.39	125.37	236.25
Total Liabilities / Total Assets	86.93	98.61	80.67	150.76	180.85
EBIT / Interest Expense	-14.42	-15.77	-13.59	-15.35	-14.96
EBITDA / Interest Expense	-14.05	-15.38	-13.15	-14.86	-14.35
(EBITDA - Capex) / Interest Expense	-14.97	-15.86	-13.61	-16.33	-14.81
Total Debt / EBITDA	-1.1	-1.02	-1.1	-1.13	-1.22
Net Debt / EBITDA	-0.08	-0.25	-0.08	-0.98	-1.12
Total Debt / (EBITDA - Capex)	-1.03	-0.99	-1.06	-1.03	-1.19
Net Debt / (EBITDA - Capex)	-0.08	-0.24	-0.08	-0.89	-1.09
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-33.34	24.76K	-78.68	704.4	91.4
Gross Profit, 1 Yr. Growth %	-29.01	86.51	16.68	12.76	51.55
EBITDA, 1 Yr. Growth %	-13.95	43.71	-14.97	1.16	-7.08
EBITA, 1 Yr. Growth %	-14.17	43.42	-14.05	1.15	-6.31
EBIT, 1 Yr. Growth %	-14.11	43.66	-14.05	1.15	-6.25
Earnings From Cont. Operations, 1 Yr. Growth %	-13.33	67.39	-13.24	0.35	-4.59
Net Income, 1 Yr. Growth %	-13.33	67.39	-13.24	0.35	-4.59
Normalized Net Income, 1 Yr. Growth %	-12.01	43.09	-12.48	-0.32	-5.69
Diluted EPS Before Extra, 1 Yr. Growth %	-15.68	39.79	-40.3	-8.44	-47
Accounts Receivable, 1 Yr. Growth %	-	-	-69.83	862.86	14.24
Inventory, 1 Yr. Growth %	-	44.84	21.57	37.32	-17.25
Net Property, Plant and Equip., 1 Yr. Growth %	25.51	5.75	-1.24	49.63	-5.83
Total Assets, 1 Yr. Growth %	-7.48	15.45	23.39	-37.74	-20.05
Tangible Book Value, 1 Yr. Growth %	-79.97	-88.85	1.79K	-263.49	27.29
Common Equity, 1 Yr. Growth %	-79.94	-87.75	1.62K	-263.49	27.36
Cash From Operations, 1 Yr. Growth %	6.93	39.82	-9.6	-1.65	-19.01
Capital Expenditures, 1 Yr. Growth %	279.3	-31.08	-0.85	187.53	-69.92
Levered Free Cash Flow, 1 Yr. Growth %	27.53	11.59	-10.96	-3.65	-22.15
Unlevered Free Cash Flow, 1 Yr. Growth %	26.94	10.67	-12.24	-3.22	-23.24
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-18.35	1.16K	628.01	30.97	292.38
Gross Profit, 2 Yr. CAGR %	-19.07	15.07	39.29	3.04	7.52
EBITDA, 2 Yr. CAGR %	-7.92	11.2	19	-7.25	-3.04
EBITA, 2 Yr. CAGR %	-7.76	10.99	19.42	-6.76	-2.65
EBIT, 2 Yr. CAGR %	-7.73	11.08	19.42	-6.76	-2.62
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.88	20.45	20.51	-6.69	-2.15
Net Income, 2 Yr. CAGR %	-5.88	20.45	20.51	-6.69	-2.15
Normalized Net Income, 2 Yr. CAGR %	-5.69	12.21	19.77	-6.6	-3.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-20.42	8.38	-8.65	-26.07	-30.34
Accounts Receivable, 2 Yr. CAGR %	-	-	-	70.45	231.66
Inventory, 2 Yr. CAGR %	-	-	32.7	29.21	6.6
Net Property, Plant and Equip., 2 Yr. CAGR %	7.37	15.21	2.2	21.57	18.28
Total Assets, 2 Yr. CAGR %	27.46	3.35	19.35	-12.35	-29.45
Tangible Book Value, 2 Yr. CAGR %	-38.23	-85.05	45.33	456.44	44.45
Common Equity, 2 Yr. CAGR %	-38.3	-84.32	45.17	430.26	44.3
Cash From Operations, 2 Yr. CAGR %	6.17	22.27	12.41	-5.71	-10.75
Capital Expenditures, 2 Yr. CAGR %	3.37	61.69	-13.31	68.84	-7
Levered Free Cash Flow, 2 Yr. CAGR %	14.4	19.29	5.88	-7.38	-13.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.05	18.52	5.01	-7.84	-13.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-30.66	442.64	224.19	652.63	48.62
Gross Profit, 3 Yr. CAGR %	-2.8	6.9	11.26	20.86	2.87
EBITDA, 3 Yr. CAGR %	5.37	6.81	6.81	12.73	-7.19
EBITA, 3 Yr. CAGR %	5.45	6.88	6.99	12.99	-6.61
EBIT, 3 Yr. CAGR %	5.47	6.94	6.99	12.99	-6.59
Earnings From Cont. Operations, 3 Yr. CAGR %	8.14	14.03	7.97	13.38	-6
Net Income, 3 Yr. CAGR %	8.14	14.03	7.97	13.38	-6
Normalized Net Income, 3 Yr. CAGR %	7.26	8.37	8.07	12.66	-6.3
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.19	-4.09	-11.16	-8.58	-33.83
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	49.17
Inventory, 3 Yr. CAGR %	-	-	-	34.22	11.37
Net Property, Plant and Equip., 3 Yr. CAGR %	15.09	6.83	9.44	16.05	11.38
Total Assets, 3 Yr. CAGR %	-5.03	23.33	9.64	-3.92	-15
Tangible Book Value, 3 Yr. CAGR %	-48.51	-65.09	-24.93	51.15	240.61
Common Equity, 3 Yr. CAGR %	-48.49	-64	-24.95	51.04	229.61
Cash From Operations, 3 Yr. CAGR %	21.02	16.38	10.55	7.51	-10.37
Capital Expenditures, 3 Yr. CAGR %	-12.97	-9.69	41.79	29.28	-4.99
Levered Free Cash Flow, 3 Yr. CAGR %	23.22	13.46	12.65	2.6	-12.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	22.04	12.25	11.86	2.19	-13.29
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-8.24	66.82	76.31	207.31	249.91
Gross Profit, 5 Yr. CAGR %	8.46	16.12	12.25	2.95	5.14
EBITDA, 5 Yr. CAGR %	12.84	16.19	10.62	3.96	2.75
EBITA, 5 Yr. CAGR %	12.98	16.27	10.84	4.19	3.03
EBIT, 5 Yr. CAGR %	12.99	16.31	10.84	4.19	3.04
Earnings From Cont. Operations, 5 Yr. CAGR %	16.07	21.91	12.93	5.24	3.8
Net Income, 5 Yr. CAGR %	16.07	21.91	12.93	5.24	3.8
Normalized Net Income, 5 Yr. CAGR %	13.52	16.68	12.1	4.93	3.48
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.75	0.83	-6.06	-13.57	-19.4
Net Property, Plant and Equip., 5 Yr. CAGR %	59.59	40.63	9.75	12.5	12.9
Total Assets, 5 Yr. CAGR %	47.23	13	4.06	7.58	-8.08
Tangible Book Value, 5 Yr. CAGR %	45.77	-50.3	-22.02	5.67	-2.46
Common Equity, 5 Yr. CAGR %	41	-49.4	-22.04	5.57	-2.52
Cash From Operations, 5 Yr. CAGR %	20.15	23.11	17.5	6.98	1.48
Capital Expenditures, 5 Yr. CAGR %	60.02	48.54	-13.11	18.22	19.78
Levered Free Cash Flow, 5 Yr. CAGR %	20.71	20.46	15.96	7.17	1.41
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.59	20.28	14.92	6.41	0.79